1. Anderson G. T. S. Esmonde S. Coles J. Macklin and C. Carnegie. 1991. A comparative study of clarithromycin and erythromycin stearate in community acquired pneumonia. J. Antimicrob. Chemother. 27(Suppl. A):117-124.
2. In vitro activity of azithromycin (Cp-62,993) against Chlamydia trachomatis and Chlamydia pneumoniae;Aqafidan A.;Antimicrob. Agents Chemother.,1993
3. Berdal P. B. P. I. Fields S. H. Mitchel and G. Hoddevik 1990. Isolation of Chlamydia pneumoniae during an adenovirus outbreak p. 445-448. In W. R. Bowie H. D. Caldwell R. P. Jones P. A. Mardh G. L. Ridgeway J. Schachter W. E. Stamm and M. E. Ward (ed.) Chlamydial infections. Proceedings of the Seventh International Symposium on Human Chlamydial Infections. Cambridge University Press Cambridge.
4. Block S. J. Hedrick M. R. Hammerschlag G. H. Cassell and J. C. Craft. Comparative safety and efficacy of clarithromycin and erythromycin ethylsuccinate suspensions in the treatment of children with community acquired pneumonia. Pediatr. Infect. Dis. J. in press.
5. Treatment of community-acquired pneumonia. A multicenter, double-blind, randomized study comparing clarithromycin to erythromycin;Chien S. M.;Chest,1993